Pulse Biosciences (PLSE) Total Current Liabilities (2015 - 2025)

Pulse Biosciences' Total Current Liabilities history runs 11 years deep, the most recent figure standing at $7.9 million for Q4 2025.

• In Q4 2025, Total Current Liabilities fell 21.2% year-over-year to $7.9 million; the TTM figure through Dec 2025 stood at $7.9 million (down 21.2% YoY), while the FY2025 annual figure was $7.9 million, down 21.2% from the prior year.
• Total Current Liabilities was $7.9 million for Q4 2025 at Pulse Biosciences, down from $9.7 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $10.1 million in Q4 2024 to a low of $5.1 million in Q1 2024.
• Historically, Total Current Liabilities has averaged $7.5 million across 5 years, with a median of $7.3 million in 2022.
• The sharpest annual moves came in 2021 and 2024: Total Current Liabilities jumped 152.08% in 2021, then decreased 27.32% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $6.7 million in 2021, then retreated by 10.84% to $6.0 million in 2022, then climbed by 12.16% to $6.7 million in 2023, then soared by 49.9% to $10.1 million in 2024, then declined by 21.2% to $7.9 million in 2025.
• The last three Total Current Liabilities figures came in at $7.9 million (Q4 2025), $9.7 million (Q3 2025), and $9.0 million (Q2 2025), per Business Quant data.